Please enable Javascript
Thierry André, MD
Articles by Thierry André, MD
CheckMate 8HW: Nivolumab Plus Ipilimumab for MSI-H/dMMR Metastatic Colorectal Cancer
Thierry André, MD
Colorectal Cancer
|
January 31, 2025
Dr. André elaborates on the efficacy and safety profiles of both treatments and their influence on current therapies.
View More
CheckMate 8HW: Nivolumab Plus Ipilimumab Versus Chemotherapy for Metastatic Colorectal Cancer
Thierry André, MD
Colorectal Cancer
|
March 13, 2025
Nivolumab plus ipilimumab showed significant improvement in progression-free survival in patients in the first line setting.
View More